Nuvectis Pharma Inc. (NVCT) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nuvectis Pharma Inc.

    NASDAQ: NVCT · Real-Time Price · USD
    6.00
    -0.07 (-1.15%)
    At close: Oct 03, 2025, 3:59 PM
    5.95
    -0.92%
    Pre-market: Oct 06, 2025, 05:19 AM EDT

    Nuvectis Pharma Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.87 -5.83 -5.05 -3.21
    PEG Ratio
    		 0.22 1.73 -0.11 -0.00
    PS Ratio
    		 n/a n/a 637.13 n/a
    PB Ratio
    		 9.53 10.63 6.68 -3.75
    P/FCF Ratio
    		 -7.56 -8.13 -7 -4.35
    P/OCF Ratio
    		 -7.56 -8.13 -7 -4.35
    OCF/S Ratio
    		 n/a n/a -91 n/a
    Debt / Equity Ratio
    		 n/a n/a n/a n/a
    Quick Ratio
    		 2.09 2.75 3.30 2.41
    Current Ratio
    		 2.09 2.75 3.30 2.41
    Asset Turnover
    		 n/a n/a 0.01 n/a
    Interest Coverage
    		 n/a n/a -129.09 n/a
    Return on Equity
    		 -1.96 -1.82 -1.32 1.17
    Return on Assets
    		 -1.02 -1.16 -0.92 -1.94
    Return on Invested Capital
    		 -2.04 -1.88 -1.33 -3.04
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a -128.09 n/a
    Net Profit Margin
    		 n/a n/a -126.09 n/a
    Pretax Profit Margin
    		 n/a n/a -128.09 n/a
    Operating Profit Margin
    		 n/a n/a -129.09 n/a
    FCF Margin
    		 n/a n/a -91 n/a
    EBITDA Margin
    		 n/a n/a -129.09 n/a

    Add to Watchlist